Ironwood Pharmaceuticals | IRWD - PE Price to Earnings


Ironwood Pharmaceuticals reported 204.24 in PE Price to Earnings for its fiscal quarter ending in December of 2024.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Almirall 79.43 0.3 Dec/2025
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amarin 91.05 88.3 Jun/2023
Astellas Pharma 9.41 6.06 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Charles River Laboratories 58.27 29 Jun/2026
Emergent BioSolutions 14.4 2.25 Sep/2022
Halozyme Therapeutics 12.51 1.15 Jun/2026
Incyte 14.45 0.9 Jun/2026
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pacira 35.68 2.9 Jun/2026
PTC Therapeutics 8.76 1.22 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 27.27 0 Mar/2026
Takeda 24.4 22.12 Jun/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023